Literature DB >> 25695140

Recombinant mouse prion protein alone or in combination with lipopolysaccharide alters expression of innate immunity genes in the colon of mice.

Elda Dervishi1, Tran H Lam, Suzana M Dunn, Grzegorz Zwierzchowski, Fozia Saleem, David S Wishart, Burim N Ametaj.   

Abstract

The objectives of this study were to test whether recombinant mouse (mo)PrP alone or in combination with LPS or under simulated endotoxemia would affect expression of genes related to host inflammatory and antimicrobial responses. To test our hypotheses colon tissues were collected from 16 male mice (FVB/N strain) and mounted in an Ussing chamber. Application of moPrP to the mucosal side of the colon affected genes related to TLR- and NLR- signaling and antimicrobial responses. When LPS was added on the mucosal side of the colon, genes related to TLR, Nlrp3 inflammasome, and iron transport proteins were over-expressed. Addition of LPS to the serosal side of the colon up-regulated genes related to TLR- and NLR-signaling, Nlrp3 inflammasome, and a chemokine. Treatment with both moPrP and LPS to the mucosal side of the colon upregulated genes associated with TLR, downstream signal transduction (DST), inflammatory response, attraction of dendritic cells to the site of inflammation, and the JNK-apoptosis pathway. Administration of moPrP to the mucosal side and LPS to the serosal side of the colon affected genes related to TLR- and NLR-signaling, DST, apoptosis, inflammatory response, cytokines, chemokines, and antimicrobial peptides. Overall this study suggests a potential role for moPrP as an endogenous 'danger signal' associated with activation of colon genes related to innate immunity and antibacterial responses.

Entities:  

Keywords:  DST, downstream signal transduction; LPS, lipopolysaccharide; NLR, NOD like receptor; PrPC, cellular form of the prion protein; TLR, toll like receptor; Ussing chamber; antimicrobial response; colon; gene expression; lipopolysaccharide; mice; moPrPC, mouse cellular prion protein; mouse cellular prion protein

Mesh:

Substances:

Year:  2015        PMID: 25695140      PMCID: PMC4601253          DOI: 10.1080/19336896.2015.1019694

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  45 in total

1.  Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens.

Authors:  Mitsutoshi Iimura; Richard L Gallo; Koji Hase; Yukiko Miyamoto; Lars Eckmann; Martin F Kagnoff
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Antibacterial activity of antileukoprotease.

Authors:  P S Hiemstra; R J Maassen; J Stolk; R Heinzel-Wieland; G J Steffens; J H Dijkman
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.

Authors:  T Fernandes-Alnemri; R C Armstrong; J Krebs; S M Srinivasula; L Wang; F Bullrich; L C Fritz; J A Trapani; K J Tomaselli; G Litwack; E S Alnemri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 4.  Cellular prion protein neuroprotective function: implications in prion diseases.

Authors:  Xavier Roucou; Andréa C LeBlanc
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

5.  Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology.

Authors:  Wei Xiang; Otto Windl; Gerda Wünsch; Martin Dugas; Alexander Kohlmann; Nicola Dierkes; Ingo M Westner; Hans A Kretzschmar
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

Authors:  M Muzio; A M Chinnaiyan; F C Kischkel; K O'Rourke; A Shevchenko; J Ni; C Scaffidi; J D Bretz; M Zhang; R Gentz; M Mann; P H Krammer; M E Peter; V M Dixit
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

7.  Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.

Authors:  M P Boldin; T M Goncharov; Y V Goltsev; D Wallach
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

8.  Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.

Authors:  Minh Dang Nguyen; Thierry D'Aigle; Geneviève Gowing; Jean-Pierre Julien; Serge Rivest
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

9.  Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin diseases.

Authors:  J Pammer; W Weninger; E Tschachler
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 10.  Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

Authors:  Marie A Bogoyevitch; Ingrid Boehm; Aaron Oakley; Albert J Ketterman; Renae K Barr
Journal:  Biochim Biophys Acta       Date:  2004-03-11
View more
  2 in total

1.  Role of polysaccharide and lipid in lipopolysaccharide induced prion protein conversion.

Authors:  Carol L Ladner-Keay; Marcia LeVatte; David S Wishart
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

2.  Distinctive Toll-like Receptors Gene Expression and Glial Response in Different Brain Regions of Natural Scrapie.

Authors:  Mirta García-Martínez; Leonardo M Cortez; Alicia Otero; Marina Betancor; Beatriz Serrano-Pérez; Rosa Bolea; Juan J Badiola; María Carmen Garza
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.